Progression of kidney disease in type 2 diabetes - beyond blood pressure control: an observational study

David J Leehey1, Holly J Kramer, Tarek M Daoud

  • 1Department of Medicine Veterans Affairs Hospital Hines, IL and Loyola University Medical Center Maywood, IL, USA. dleehey@lumc.edu

BMC Nephrology
|June 30, 2005
PubMed
Abstract

Insights

In type 2 diabetes mellitus patients with chronic kidney disease, low albumin and proteinuria, not blood pressure, predict kidney disease progression. These findings highlight potential therapeutic targets for managing diabetic kidney disease.

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Risk factors for chronic kidney disease (CKD) progression in type 2 diabetes mellitus (DM) require further elucidation.
  • While uncontrolled blood pressure (BP) is known to harm kidneys, other factors may be more critical once BP is managed.

Purpose of the Study:

  • To identify factors independently associated with the progression of kidney disease in patients with type 2 diabetes and CKD.
  • To investigate the role of blood pressure, glycated hemoglobin, and serum cholesterol in CKD progression after controlling for BP.

Main Methods:

  • Retrospective evaluation of 343 patients with type 2 DM and CKD between 1993 and 2002.
  • Glomerular filtration rate (GFR) decline rate estimated using the MDRD formula to assess kidney disease progression.
  • Univariate and multivariate analyses to determine independent predictors of CKD progression.

Main Results:

  • Low initial serum albumin, black race, and degree of proteinuria were independently associated with CKD progression (p < 0.001, p < 0.001, and p = 0.002, respectively).
  • Blood pressure, glycated hemoglobin, and serum cholesterol levels were not independently associated with kidney disease progression in this cohort.
  • Mean GFR decline was 4.5 ml/min/1.73 m²/yr, with significant variability.

Conclusions:

  • In type 2 diabetic patients with CKD and controlled BP (<140/80 mmHg), hypoalbuminemia and proteinuria are significant independent predictors of kidney disease progression.
  • These potentially modifiable factors, hypoalbuminemia and proteinuria, warrant further investigation for therapeutic interventions in diabetic kidney disease.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...